Hubei Yuancheng Saichuang Technology Co. Ltd
Products
Contact Us
  • Contact Person : Mr. gloria cui
  • Company Name : Hubei Yuancheng Saichuang Technology Co. Ltd
  • Tel : 86-027-50756026
  • Fax : 86-027-68886696
  • Address : hubei,wuhan,No. 496 Zhongshan Road, Wuchang District
  • Country/Region : China
  • Zip : 430064

Sunitinib Malate CAS 341031-54-7 (skype:ycsclee123)

Sunitinib Malate CAS 341031-54-7 (skype:ycsclee123)
Product Detailed
Related Categories:Herbal Medicine
Sunitinib Malate CAS 341031-54-7 (skype:ycsclee123) key words:Sunitinib Malate, CAS 341031-54-7, Anti-Cancer Hi!I am gloria, please feel free to contatc me: skype:ycsclee123 ; email:ycgc912 at yccreate dot com;whatsapp:+8613007130937 *.Basic info: product name: Sunitinib malate Chinese alias: N- (2- (two ethyl amino) ethyl) -5- ((Z) - (5- -1,2- two -2- fluoride hydrogen oxygen generation -3H- indole -3- subunit) methyl) -2,4- two methyl -1H- pyrrole -3- formamide (2S) - hydroxy acid salt; sunitinib malate; sunitinib malate English name: N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene) methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate CAS: 341031-54-7 molecular formula: C22H27FN4O2.C4H6O5 Molecular weight: 532.566 Appearance: Red powder Melting point: 189℃~191℃ Assay: 99% Packing: 1kg aluminum foil bag or packaged according to customer requirements MOQ: 10g supply ability: mass stock *.Application: Sunitinib malate by preventing cancer cells of blood and nutrients needed for growth play a role in the treatment. Clinical trials show that the medicine, can delay the gastrointestinal stromal tumor growth speed, and can reduce the size of renal cell cancer. Sunitinib malate is the first to selectively target multiple tyrosine kinase receptor model targeting drugs, combined with the suspension to the anti angiogenic blood supply of tumor cells and tumor directly attack the tumor cell two mechanisms. It represents a new round of the advent of targeted therapies, which can directly attack the tumor toxicity, nor conventional chemotherapy.


Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.